Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02158858
Title A Phase 2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Myelofibrosis
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Constellation Pharmaceuticals
Indications

myelofibrosis

Therapies

CPI-0610 + Ruxolitinib

CPI-0610

Age Groups: adult | senior
Covered Countries USA | CAN


No variant requirements are available.